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FREE-FOR-ALL: PUBLIC ACCESS AND
PUBLISHER RIGHTS COLLIDE IN
THE FAIR COPYRIGHT IN RESEARCH WORKS
ACT OF 2009
I. INTRODUCTION
With its current annual budget of $30.5 billion,' the National
Institutes of Health ("NIH") makes no small mark in the field of
competitive research grant funding. More than eighty percent of
that number is awarded to researchers around the world to fund
their research,2 the very research that fuels global advances in life
science and medicine. Naturally, because the NIH is a federal
agency, its full budget comes from the allowances Congress makes
for it in various appropriation and spending bills. This money
comes from the taxes we all pay each year; therefore, it is not a
difficult leap to consider the issue at the root of the public access
controversy. If the taxpayers funded the research on the front end,
why should they be subjected to the sky-high journal subscription
prices necessary to read the research when it is published? Did
President Obama not promise that transparency, participation, and
collaboration would be the hallmarks of his administration?3
Surprisingly, the public access policy instituted by the NIH and the
resulting legislation proposals have become the source of one of
the most heated intellectual property debates that Washington has
seen in some years. This debate represents not only an opportunity
for President Obama to reinforce his commitment to transparency,
but also his chance to show that open government is fully
compatible with our existing safeguards for intellectual property
protection.
This Article addresses a recent piece of legislation to come into
the public access fray: The Fair Copyright in Research Works Act
1. See Omnibus Appropriations Act, 2009, Pub. L. No. 111-8 § F(II), 123
Stat. 524.
2. Id.
3. See Transparency and Open Government, 74 Fed. Reg. 4685-86 (Jan. 26,
2009) ("My Administration is committed to creating an unprecedented level of
openness in Government. We will work together to ensure the public trust and
establish a system of transparency, public participation, and collaboration.").
1
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- House Resolution 801 ("H.R. 801"). It begins with Section II, a
background discussion of the two competing interests fueling this
debate. Part A describes the taxpayers' perceived right to free
access to federally-funded medical research. Part B describes the
journal publishing industry's desire to stay financially sound
enough to continue to provide its services. Part C of the
Background section provides the roadmap to H.R. 801 and the
development of the NIH public access policy. Part D briefly
discusses H.R. 801 's predecessor bill, H.R. 6845.
Section III will delve into H.R. 801 itself. Part A will discuss
the provisions of H.R. 801 and the direct conflicts they make with
the NIH's public access policy. Part B outlines the arguments
made by the bill's supporters, with Part C providing the responses
of the opposing side.
Finally, Section IV explores the possibility of an amicable
resolution. Part A will discuss the lessons to be learned from two
previous legislations on similar topics, America COMPETES and
the Bayh-Dole Act. Part B will consider the issues that will be
central to resolving the public access conflict. Lastly, Part C will
outline a proposed solution that will hopefully placate both sides.
II. BACKGROUND
A. Taxpayers'Access to Federally-Funded Medical Research
With American taxpayers funding medical research to the tune
of more than $30 billion per year,4 it is no small wonder that they
expect some sort of return on that investment.' Beyond wanting
access to this information for themselves, they want to ensure that
4. See supra note 1.
5. Press Release, Alliance for Taxpayer Access, CALL TO ACTION: Ask
Your Representative to Oppose the H.R. 801 - The Fair Copyright in Research
Works Act (Feb. 11, 2009) (on file with author) "H.R. 801 is designed to amend
current copyright law and carves out a subclass of copyrighted works... -
precisely those that are supported by taxpayers - and makes it illegal for the
government to require that that special subclass by [sic] made freely available to
taxpayers as a condition of the federal support." Id.
[Vol. XX: I
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doctors and researchers around the world have the NIH's research
to build on in their ventures to cure the world's sicknesses.6
Internet access is now commonplace in the American household,
and patients use public access policies to participate in their own
care and treatment. It is not rare to have newly diagnosed cancer
patients approach their doctors with their own research, hoping
that this new collaborative care will increase their chances of
survival.
During a Congressional Subcommittee hearing on a previous
version of the Fair Copyright in Research Works Act ("H.R.
6845"), the Subcommittee heard oral testimony from Heather
Joseph, appearing not only on behalf of the Scholarly Publishing
and Academic Resources Coalition, but also as the mother of a
diabetic child.7 She shared with the Subcommittee her frantic
early morning Internet search, moments after returning from the
hospital where they had learned of her son's diagnosis.8 During
that search, she came upon a study rating glucose monitors that
would help her keep her son's insulin level under control
overnight.9 What she found was not a published journal article; it
was the author's final manuscript deposited in PubMed Central
("PMC") as a direct result of the NIH policy. 0 This testimonial is
a persuasive illsutration in support of the NIH's public access
policy.
An elementary schoolteacher, Mary Hutchings of Truro,
Massachusetts wrote to the Subcommittee and shared a story about
her access to research on a rare disease affecting both her husband
and daughter. " She told the committee that after half of her
6. See id. "H.R.801 would ... seriously imped[e] the ability of researchers,
physicians, health care professionals, and families to access and use this critical
health-related information in a timely manner." Id.
7. The Fair Copyright in Research Works Act: Hearing on H.R. 6845 Before
the Subcomm. on Courts, the Internet and Intellectual Property of the H. Comm.
on the Judiciary, 1 10th Cong. 58 (2009) [hereinafter Hearing] (testimony of
Heather Dalterio Joseph, Executive Director, Scholarly Publishing and
Academic Resources Coalition).
8. Id. at 59.
9. Id.
10. Id.
11. Id. at app. at 166 (letter submitted to the hearing record by Mary
Hutchings).
3
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family was diagnosed with cerebellar ataxia, her only respite from
her anxieties was reading new research that promises new
therapies for the disease. 2 She described her frustrating search for
papers that she could read for free, as her tiny town lies at the far
end of Cape Cod, miles from any research hospitals or university
libraries." 3 Mary Hutchings' experience is not unusual, and she
felt that H.R. 6845 would restrict her access even further and deny
her the solace she found in reading up-to-date research for free
online. 14
B. The Scientific, Technical, & Medical 5 Journal Publishing
Industry
Though providing free access to medical research seems to be an
easy decision, the reality is that there is an entire industry that
survives by publishing this research for a price. STM publishers
are a common avenue by which researchers communicate their
research results to colleagues around the world.16 These publishers
can range from worldwide organizations with millions of dollars in
annual profit to the smallest non-profit groups whose mission
statements mirror exactly the access goals of the NIH policy.
Nevertheless, commercial or non-profit, these groups require an
influx of money to continue to operate. Free access cannot come
free.
A look at the process of having an article published in a journal
demonstrates the benefits journals provide to the publishing
process and why they must be preserved. Once researchers have
finished their work, compiled their data, and produced a
manuscript, they must find a journal willing to invest in the
publication of their work. It is estimated that between fifty and
12. Id.
13. Hearing, supra note 7 at app. at 166 (letter submitted to the hearing
record by Mary Hutchings).
14. Id.
15. In the publishing world, these journals are referred to collectively as
"STM" publications.
16. See, e.g., International Association of Scientific, Technical & Medical
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ninety percent of articles submitted for publication are rejected. 7
The journal's editors read manuscripts to determine which
showcase research is both on the cutting edge of the industry and
will be of interest to the journal's readers.' 8 Once an article is
selected for publication, it will be subjected to multiple peer
reviews. 9 Here, the journal contacts other researchers in the field
who volunteer to review the article for scientific validity and other
qualifications.2" The journal coordinates the entire peer review
process, which can last for months and require multiple periods of
comment and revision.2' At that time, the journal will begin the
copyediting and formatting process that will transform the final
manuscript into a published article.22
When one considers the sheer volume of research conducted
around the world and submitted to these journals, the time and
manpower provided by journal publishers in their efforts to
provide the most recent and highest quality research to their
readers is not a small investment. It is precisely this investment
that publishing companies are looking to protect when they
support H.R. 801.23
C. An Attempt to Meet in the Middle - The NIH Public Access
Policy
In 2003, tensions between publishers and public access
advocates were rising, followed closely by medical journal
subscription costs. The increase in the average annual subscription
price for a medical journal from 1997 to 2003 was a staggering
17. Hearing, supra note 7 at 93 (2009) (oral testimony of Dr. Martin Frank,
Executive Director, American Physiological Society).
18. See id. at 77 (describing generally the process of publication from article




22. Id. at 93 (2009) (oral testimony of Dr. Martin Frank, Executive Director,
American Physiological Society).
23. See Hearing, supra note 7 at 71 ("By protecting copyright, the act will
continue to provide incentives for investment in the peer review process, which
helps ensure the quality and integrity of scientific research.").
5
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83.7%, from $461.60 to $847.76.24 Congress took a seat at the
public access table by inserting language about the growing
concern over rising journal subscription prices into the House
Labor, Health and Human Services, and Education Bill of FY
2004.25 As the NIH began to develop a preliminary public access
policy, Congress preempted its efforts by requesting a policy that
would require NIH-funded researchers to submit their final
manuscripts to the NIH for publication in a yet-to-be-developed
online database within six months of the article's publication in a
medical journal. 26  The NIH applied a less stringent version of
Congress' suggestions and announced in February 2005 that it had
crafted a policy that only suggested deposition of final, peer-
reviewed manuscripts into the online database, along with the
embargo time period on online publication that stretched from six
months to twelve.27 Authors were not required to submit the final
journal version of the article that had been subjected to copy-
editing and formatting. 2 The NIH launched PMC, the online
research database, with these voluntary provisions on May 2,
2005.29
After nearly a year of low participation levels hovering
24. 17th Annual Study of Journal Prices for Scientific and Medical Society
Journals: 2004 Pricing Trends for U.S. Society Journals and Ten
Recommendations for Pricing 2005 Volumes, THE NEWSLETTER FOR JOURNAL
PUBLISHERS (Allen Press, Inc., Lawrence, KS), 2004, at 6.
25. H.R. REP. NO. 108-188, at 89 (2004) ("The Committee is concerned by
reports that there has been a significant change in the availability of research
data internationally and a dramatic rise in medical research data subscription
costs. NLM is encouraged to examine how the consolidation of for-profit
biomedical research publishers, with their increased subscription charges, has
restricted access to vital research information to not-for-profit libraries.").
26. ALLIANCE FOR TAXPAYER ACCESS, PUBLIC ACCESS TIMELINE ON
CAPITOL HILL (2007), available at http://www.taxpayeraccess.orgbm-doc/publ
icaccesstimeline-07-sept.pdf
27. Press Release, National Institutes of Health, NIH Calls on Scientists to
Speed Public Release of Research Publications (Feb. 3, 2005) (on file with
author).
28. Id. (defining what must be deposited as "the final version accepted for
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somewhere near seven percent,3" support gathered both in
Congress and in the NIH's own Public Access Working Group for
a reversion to Congress' original suggestion of a mandatory
policy. In December 2007, President Bush signed the
Consolidated Appropriations Act of 2008. 3" Attached to this
massive piece of legislation was a small provision directing the
NIH to make compliance with the public access policy
mandatory.32 Shortly thereafter, the NIH entered into a period of
public comment and issued a request for information regarding the
implementation of the new policy.33 This period lasted from
March 28 to May 31, 2008."4 The comments received during this
period were compiled into a pamphlet by the NIH and were largely
reflected by the comments raised by supporters and detractors
alike in the Congressional Hearing on H.R. 6845." 5 During that
period, on April 7, 2008, the policy went into effect, requiring
deposit into PMC of every paper accepted for publication from
that day on.36
As the situation stood in April of 2008, when the floodgates to
billions of dollars of research were wide open, the public access
policy was still subject to an annual renewal.37 President Obama
removed this hurdle when he signed the Omnibus Appropriations
30. NAT'L INSTS. OF HEALTH, ANALYSIS OF COMMENTS AND
IMPLEMENTATION OF THE NIH PUBLIC ACCESS POLICY at 26 (Sept. 30, 2008).
31. Statement on Signing the Consolidated Appropriations Act, 2008, 43
WEEKLY COM. PRES. DOC. 1638 (Dec. 26, 2007).
32. See Consolidated Appropriations Act, 2008, Pub. L. No. 110-161, §
G(II)(218), 121 Stat. 1844, 2187 ("The Director of the National Institutes of
Health shall require that all investigators funded by the NIH submit or have
submitted for them to the National Library of Medicine's PubMed Central an
electronic version of their final, peer-reviewed manuscripts upon acceptance for
publication, to be made publicly available no later than 12 months after the
official date of publication: Provided, That the NIH shall implement the public
access policy in a manner consistent with copyright law.") (emphasis added).
33. NAT'L INSTS. OF HEALTH, supra note 30 at 1.
34. Id.
35. Id.
36. Id. at 6.
37. Press Release, Alliance for Taxpayer Access, First U.S. Public Access
Policy Made Permanent (Mar. 12, 2009) (on file with author) (stating that the
policy had previously been implemented with a provision that was subject to
annual renewal).
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Act of 2009. At last, it seemed the goal of providing free public
access to medical research published in journals had been
accomplished. 9
D. House Resolution 6845 -The Fair Copyright in Research
Works Act [I]
However, not all were satisfied. Journal publishers, researchers,
and other intellectual property advocates read into the NIH policy
a severe trespass on the copyrights of the authors and publishers of
these articles. In a swift response to the progression of the NIH
Public Access Policy from mere Congressional suggestion into
law, H.R. 6845 came onto the scene. Introduced by Democratic
Congressman John Conyers on September 9, 2008, its text was
identical to that of H.R. 801, the bill discussed in the bulk of this
article °.4  H.R. 6845 would have abolished the new NIH policy and
specifically forbidden any other federal government agencies from
implementing similar policies. 1 On September 11, 2008, the bill
was subjected to a hearing before the Subcommittee on Courts, the
Internet, and Intellectual Property. 2  At that time, the
Subcommittee heard testimony from then-director of the NIH, Dr.
Elias Zerhouni, and the Executive Director of the American
Physiological Society, Dr. Martin Frank.43  These men, among
other qualified and impassioned witnesses, provided extensive
opinions on the validity and necessity of the bill. Ultimately, the
110th Congress came to an end before any decisions were made on
38. See Omnibus Appropriations Act, 2009, Pub. L. No. 111-8, § F(217), 123
Stat. 524, 782 ("The Director of the National Institutes of Health shall require in
the current fiscal year and thereafter that all investigators funded by the NIH
submit or have submitted for them to the National Library of Medicine's
PubMed Central an electronic version of their final, peer-reviewed manuscripts
upon acceptance for publication to be made publicly available no later than 12
months after the official date of publication: Provided, That the NIH shall
implement the public access policy in a manner consistent with copyright law.")
(emphasis added).
39. See Press Release, Alliance for Taxpayer Access, supra note 37.
40. Fair Copyright in Research Works Act, H.R. 6845, 110th Cong. (2008).
41. See infra note 48 (providing full relevant text of identical bill H.R. 801).
42. See generally Hearing, supra note 7.
43. Id. at III.
[Vol. XX: I
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H.R. 6845. The wealth of professional opinions provided in the
hearing on September 11 could have been an invaluable resource
for the bill sponsors, allowing them the opportunity to incorporate
those thoughts and suggestions into a new draft of the bill.
Instead, no changes were made and the identical text was
introduced to the House of Representatives on February 3, 2009,
this time under the heading of House Resolution 801.'
III. PROPOSED LEGISLATION: H.R. 801 - THE FAIR COPYRIGHT IN
RESEARCH WORKS ACT
A. Summary of the Proposed Legislation
As noted above, H.R. 801 came immediately after H.R. 6845,
and the two texts are identical. Therefore, the September 11, 2008
hearing on H.R. 6845 will be used here as criticism and comment
on H.R. 801 itself, as no hearing has yet been scheduled for the
latter.
H.R. 801 is not a lengthy bill; it concisely seeks to prohibit
mandatory public access policies like the policy currently in place
at the NIH.45 Generally, the purpose of the bill is "[t]o amend title
17 of the United States Code, with respect to works connected to
certain funding agreements."46 It would add a new subsection at
the end of Section 201 of title 17 by implementing limitations on
federal agencies' research funding agreements.4 7  Three
subparagraphs set out restrictions on the copyright terms of
funding agreements, specifically stating that federal agencies may
not impose terms that require transfer or license of any copyrights
in extrinsic works, impose a waiver of any of these provisions as a
condition of funding, or assert any copyrights in work performed
under a funding agreement that restrains the author's rights.48 The
44. Fair Copyright in Research Works Act, H.R. 801, 111 th Cong. (2009).
45. Id.
46. Id.
47. Id. at § 2(a).
48. Id. Sections 2(f)(1)(A-C) of the proposed new subsection state fully what
a federal agency may not do in connection with a funding agreement:
(A) impose or cause the imposition of any term or condition that--
9
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remaining subparagraphs define essential terms and provide that
this new section applies to any work "based on, derived from, or
related to, a funding agreement" that is also funded by at least one
other entity that is not a federal agency or that reflects "meaningful
added value" contributed by one or more entities that are not
federal agencies, or party to or an agent of a party to the funding
agreement.49 The final portion of the bill states that the Register of
Copyrights shall submit a report to Congressional committees
discussing the implementation of the new section in the context of
new developments in access to the resulting research of these
funding agreements."
(i) requires the transfer or license to or for a Federal agency of--
(I) any right provided under paragraph (3), (4), or (5) of section 106 in an
extrinsic work; or
(II) any right provided under paragraph (1) or (2) of section 106 in an
extrinsic work, to the extent that, solely for purposes of this subsection, such
right involves the availability to the public of that work; or
(ii) requires the absence or abandonment of any right described in subclause
(I) or (II) of clause (i) in an extrinsic work;
(B) impose or cause the imposition of, as a condition of a funding agreement,
the waiver of, or assent to, any prohibition under subparagraph (A); or
(C) assert any rights under this title in material developed under any funding
agreement that restrain or limit the acquisition or exercise of rights under this
title in an extrinsic work.
Id.
49. Section (f)(3)(A) defines what constitutes an extrinsic work under this
bill:
(A) EXTRINSIC WORK- The term 'extrinsic work' means any work, other than
a work of the United States Government, that is based upon, derived from, or
related to, a funding agreement and--
(i) is also funded in substantial part by one or more other entities, other than
a Federal agency, that are not a party to the funding agreement or acting on
behalf of such a party; or
(ii) represents, reflects, or results from a meaningful added value or process
contributed by one or more other entities, other than a Federal agency, that are
not a party to the funding agreement or acting on behalf of such a party.
Id.
50. Section 2(c) provides for specifics of the required reports to House and
Senate Committees:
(c) Report to Congressional Committees- Not later than the date that is 5 years
after the date of the enactment of this Act, the Register of Copyrights shall, after
consulting with the Comptroller General and with Federal agencies that provide
funding under funding agreements and with publishers in the private sector,
136 [Vol. XX: I
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B. Responses
This section outlines the primary arguments both for and against
H.R. 801. It is important to note that the supporters and detractors
of this bill are diverse across many demographic strata,5' therefore
making it difficult to profile how any one industry or individual
will react. However, it is clear that each party involved indeed
supports the spirit of open public access. 2 Ultimately, a mutually
satisfactory solution would need to reflect the need to preserve
intellectual property rights at hand, the promotion of medical
professionals into a healthy collaborative-care relationship with
their patients, and the advancement of science as a whole.
As noted previously, no hearing date has yet been set for H.R.
801. Therefore, a significant amount of the information contained
in this section is drawn from the September 11, 2008 hearing on
H.R. 6845 before the Subcommittee on Courts, the Internet, and
Intellectual Property. 3
1. All in Favor of H.R. 801...
As evidenced by testimony at the H.R. 6845 hearing and the
support letters attached thereto, the Fair Copyright in Research
Works Act has garnered support from some of the most prestigious
names in the scientific and publishing communities. These
review and submit to the appropriate congressional committees a report on the
Register's views on section 201(f) of title 17, United States Code, as added by
subsection (a) of this section, taking into account the development of and access
to extrinsic works and materials developed under funding agreements, including
the role played by publishers in the private sector and others.
Id.
51. See infra Sections III(B)(1) and III(B)(2)
52. See Hearing, supra note 7 at 14 (oral statements of Congressman Darrell
Issa) ("We want [the public] to have the data. We want them to have the
knowledge. What is very clear is in the promotion of the publications that we
want published, we want to maintain the benefit ordinarily accorded to
copyrights, and that is really the balancing act that I know we are going to hear
about today and that [sic] we are going to try to achieve with this legislation is
exactly that.").
53. See generally Hearing, supra note 7.
54. Among others, the following organizations and individuals submitted
letters to the hearing record in support of H.R. 6845: Association of American
11
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supporters have grave concerns with the current NIH policy and
see H.R. 801 as a potential remedy for the many implicated
problems. Among those concerns are questions about the policy's
validity with respect to copyright law," the economic
ramifications for both for-profit and non-profit journal
publishers,56 the future preservation of the integrity of the
scientific record, and the sufficiency of systems already in place to
accomplish the goal of widespread public access. 7  A few
supporters have also expressed concerns about the NIH's ability
and willingness to collaborate on an initiative to develop a
compromise. 58
Publishers, American Physiological Society, Optical Society of America,
Software and Information Industry Association, American Association of
Physicists in Medicine, Washington DC Principles for Free Access to Science,
American Association of Physics Teachers, American Chemical Society, and
the University of Chicago's Vice President for Research and National
Laboratories. Hearing, supra note 7 at app.
55. Hearing, supra note 7 at 50 (testimony of Ralph Oman, former Register
of Copyrights) ("My basic concern about the new NIH public access proposal is
its dilution of the rights of the copyright owners .... The NIH policy, in fact,
should change in a way that respects the spirit and letter of the copyright law. In
that way, we could achieve the basic constitutional purpose of copyright, and
that is to promote the progress of science and advance leaming and, in that way,
reach a broad audience for these extremely important manuscripts that are
produced with the funding of the National Institutes of Health.").
56. Id. at 54 ("My basic concern about the NIH proposal is that it will, sooner
rather than later, destroy the commercial market for these scientific, technical,
and medical journals.").
57. Hearing, supra note 7 at app. at 117 (letter submitted to the hearing
record by Dr. Martin Frank on behalf of APS in response to Congressman
Berman's November 12, 2008 Request) ("NIH is not the only organization
providing public access to the scientific literature."). The letter goes on to
describe in detail the existing public access avenues including PatientlNFORM,
publisher's own websites, universities' public information offices, HINARI,
AGORA, and OARE.
58. Hearing, supra note 7 at 119 (letter submitted to the hearing record by
Dr. Martin Frank on behalf of APS in response to Congressman Berman's
November 12, 2008 Request) ("Unfortunately, NIH has decided to work at cross
purposes to efforts of publishers .... By creating its own standard, NIH is
competing with existing industry standards. This duplication is wasteful and
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a. Copyright Implications
The potential copyright implications of the public access policy
are the focus of H.R. 801. Many supporters of the bill argue that
the NIH policy constitutes an involuntary transfer of intellectual
property rights, something that is specifically forbidden by the
Copyright Act.59 All NIH research grants are conditional on
compliance with the current public access policy.6" There are
three separate allegedly involuntary transfer transactions that
concern this group. The first is the transfer of the right to display
and publish the article in PMC from the author to the NIH.61 The
second is the transfer of the right to display and publish the
journal's added value of peer review to the NIH.62 Third is the
transfer of the right to display and publish any additional work
contained in the manuscript not funded by the NIH.63
When researchers agree to accept NIH grants, they agree to
transfer to the NIH the right to publish and display their final
59. 17 U.S.C. § 201(e) ("When an individual author's ownership of a
copyright, or of any of the exclusive rights under a copyright, has not previously
been transferred voluntarily by that individual author, no action by any
governmental body or other official or organization purporting to seize,
expropriate, transfer, or exercise rights of ownership with respect to the
copyright, or any of the exclusive rights under a copyright, shall be given effect
under this title except as provided under title 11.").
60. See NIH Public Access Policy Details, http://publicaccess.nih.gov/policy
.htm (last visited Jul. 31, 2009).
61. Hearing, supra note 7 at app. at 109-10 (letter submitted to the hearing
record by Allan Adler, Vice President for Legal & Government Affairs,
Association of American Publishers) ([A]t this stage of the evolution of the NIH
policy, it is ludicrous to attempt to characterize it as 'voluntary' for the
investigator in any meaningful sense .... By its own terms, the NIH policy is
clearly coercive, putting investigators on notice that lack of compliance with its
manuscript submission requirement will place the possibility of future grants to
the same investigator at risk. Where the NIH previously took pains to assert that
its initial Public Access Policy 'upholds the principles of copyright' because
'submission of the final manuscript is voluntary rather than mandatory,' it no
longer attempts to make this argument.").
62. Id. at 110 ("[T]he NIH policy and its associated license do not merely
encumber the copyright acquired by the publisher; they denude it.").
63. Hearing, supra note 7 at 55-56 (testimony of Ralph Oman) ("Will the
NIH commandeer the rights of those [non-NIH-funded researchers] creators as
well.. . ?").
13
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manuscripts on PMC.6 4  Though it is a non-exclusive right,
meaning they may grant others the right to publish and display the
manuscript as well, the right of first publication is the one that is
highly regarded and sought by journal publishers.65 If this right
has been previously licensed to another entity, the economic value
of that right is diminished. Traditionally, the transfer of this right
is what encourages publishers to invest the time and money into
preparing an article for publication.66 Although accepting the
grant and thereby accepting the transfer appears to be voluntary,
many make the point that it is not entirely so. As noted above, the
NIH funds vast amounts of research in the United States.67 In a
letter in support of H.R. 6845 submitted as part of the
Congressional hearing record, the American Association of
Publishers suggested that voluntary refusal of NIH funding due to
an objection to the transfer is not only unlikely, due to the prestige
and influence of the agency in the field, but also foolhardy, 68 as the
NIH itself states that refusal to comply with the public access
policy could place the possibility of future grants to that researcher
at risk.69 Put another way, authors are given the "choice" between
64. See NIH, supra note 60.
65. See Hearing, supra note 7 at app at 110 (letter submitted to the hearing
record by Allan Adler, Vice President for Legal & Government Affairs,
Association of American Publishers).
66. Hearing, supra note 7 at app at Il1 (letter submitted to the hearing
record by Allan Adler, Vice President for Legal & Government Affairs,
Association of American Publishers) ("[T]he performance of these publishing
services constitutes valuable consideration that the journal publisher provides to
the manuscript author in explicit expectation of the author's transfer of
copyright in the manuscript to the publisher following acceptance for
publication. Journal publishers rely on copyright transfers to ensure that they
have all of the rights that are essential to support their investments in the
publishing enterprise.").
67. See supra note 1.
68. Hearing, supra note 7 at 109-10 (letter submitted to the hearing record by
Allan Adler, Vice President for Legal & Government Affairs, Association of
American Publishers) (stating that the common assertion that a researcher has a
choice about accepting NIH funding is "untenable" and "ludicrous.").
69. Nat'l Insts. of Health, http://publicaccess.nih.gov/FAQ.htm (last visited
Jul. 30, 2009) (stating that one possible course of action the NIH may take in
response to non-compliance is proactive action "precluding the grantee from
obtaining future awards.").
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signing away their rights or never accepting funds from the NIH
again, so long as the public access policy that they object to is in
place. During his written testimony,7" former Register of
Copyrights Ralph Oman went so far as to say that the funding
contracts are contracts of adhesion.71
The second worrisome transfer of rights is the appropriation of
the value added by the journals, who are third parties to the
contracts where the NIH reserves its rights to publish and display
the articles. This issue has its roots in the argument between the
NIH and publishers about who in fact pays for the peer review
process. 7' Assuming here, for the benefit of H.R. 801 supporters,
that the time and monetary costs of peer review are borne by the
publisher, the value added to an article via the peer review process
should be owned by the journal publishers. However, the NIH
policy mandates that authors submit their final, peer-reviewed
manuscripts to PMC. 73  In fact, Dr. Zerhouni explicitly stated
during his testimony that articles that have not undergone the peer
review process would not be acceptable as PMC submissions and
that the public's reliance on manuscripts that had not been
reviewed would be dangerous and undesirable.7 ' Thus, with
70. Hearing, supra note 7 at app at 126 (Responses of Ralph Oman to the
Written Questions of the Subcommittee Members submitted to the hearing
record) ("The assignments from the author are 'negotiated' deceptively, and the
authors are presented with a take-it-or-leave-it contract that they are forced to
sign without truly understanding the consequences. They are contracts of
adhesion, and they run counter to the underlying spirit of copyright, which seeks
to protect the weak from the powerful.").
71. An adhesion contract is a standard-form contract prepared by one party,
to be signed by the party in a weaker position ... who adheres to the contract
with little choice about the terms. BLACK'S LAW DICTIONARY, 366 (9th ed.
2009).
72. Compare Hearing, supra note 7 at 71 (oral testimony of Dr. Martin
Frank) ("While the agencies pay for the research, the publisher bears the cost of
peer review and publishing.") with Hearing, supra note 7 at 82 (oral testimony
of Dr. Elias Zerhouni) ("Currently, Mr. Chairman, NIH pays for peer review
costs.").
73. NIH, supra note 60. The clause in the public access policy regarding
what version must be submitted reads "an electronic version of their final, peer-
reviewed manuscripts." Id.
74. Hearing, supra note 7 at 92 (oral testimony of Dr. Elias A. Zerhouni,
Director, National Institutes of Health).
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researchers acquiescing to funding agreements that essentially sign
away the peer review value contributed by their eventual
publishers, it may be difficult to conclude that the transfer was
voluntarily made between the journal and the NIH. Again we
come to the idea of adhesion contracts. Publishers want the best
research, and researchers want the best funding, so it is difficult to
find a true fairness in these "voluntary" transfers.
The final potential involuntary transfer is of the rights of authors
and researchers who contributed to an NIH-funded manuscript but
who were not NIH-funded themselves.75 This could also include
an NIH-funded author's use of diagrams or photographs that the
author does not own. 6 This issue was raised rhetorically by Mr.
Oman in his written testimony at the H.R. 6845 hearing.77 He
postulated, without answer or rebuttal from the other side, that the
negotiation of these ancillary rights would become a licensing
issue beyond the scope of what authors are equipped to deal with."8
For now, when these issues arise, the publisher's legal department
assists with the navigation of this legal quagmire.79 This situation
presents a similar involuntary transfer as the problem presented
above. These other researchers and contributors are not party to
the NIH-funded author's agreements; yet, that one author has
licensed the NIH to publish and display the article in its entirety.
These copyright questions present a complication that goes to
the core of goal of the NIH policy. If journal publishers and other
authors choose not to associate with NIH-funded authors because
of their preexisting agreement with the NIH, which ultimately
transfers the rights of more than just that author, is the field of
science truly being advanced by the public access policy?
b. Potential Economic Impact
Because H.R. 801 seeks to amend the Copyright Act, its
potential impacts on the intellectual property rights of the parties
involved are the focus of the campaigns in support of the bill.
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However, supporters feel that the passage of the bill would have a
long-reaching impact on the economic health of the academic
publishing industry. In their eyes, the bill would put a sandbag in
front of the anticipated deluge of journal subscription cancellations
and profit losses expected to follow in the footsteps of the public
access policy. 80
The economic arguments on behalf of H.R. 801 paint a picture
that begins with free public access to journal content and ends with
the collapse of the publishing industry and the peer review system
it supports. Many argue that increased access will result in the
cancellation of journal subscriptions by libraries and universities
across the world.81 If subscribers can receive full article texts
online for free, they argue, it will be difficult to sell them annual
subscriptions.82 When subscription funds run dry, the peer review
system will suffer.83 With potential subscribers linking to articles
within PMC instead of from and between the journals' websites,
even advertising dollars could be lost.84 In his hearing testimony
in support of H.R. 6845, Dr. Frank shared with the Subcommittee
the budget allotted for peer review by the American Physiological
Society ("APS").8 5 Peer reviewers themselves are not always paid
for their services; yet, twenty percent of the APS' $13 million
publishing budget is spent on the peer review process.86 The loss
of peer review systems and subscription funds would spell disaster
80. Id. at 81 (written testimony of Dr. Martin Frank) ("This important
legislation will help ensure that the federal government does not diminish
copyright protections for scientific journal articles in which private-sector
publishers have made a significant value-added contribution. By protecting
copyright for research works, HR __ [sic] will continue to provide incentives
for private-sector investment in the peer review process which helps ensure the
quality and integrity of scientific research.").
81. Hearing, supra note 7 at 80 (written testimony of Dr. Martin Frank).
82. Id.
83. Id. at 78-79.
84. See id. at 97.
85. See id. at 86. Dr. Frank stated that 20 percent of the APS $13 million
publication budget is spent on the coordination and completion of the peer
review process.
86. Id. at 86. Dr. Frank described the aspects of the peer review process
supported by this budget, including development of an online submission and
review system, editorial office and associate editor support, and a full staff to
coordinate the process.
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for the journal publishing industry as a whole.87 Journals would be
forced to close their doors, they fear, resulting in a smaller pool of
available journals to publish in."8 This may become restricted
even further by journals who refuse to publish any NIH-funded
research as a measure to keep their content in their own hands.
Supporters extol H.R. 801 as a measure that would restore a free
market in the industry. 9 Mr. Oman appealed to the Subcommittee
to allow scientific journals to compete fairly in a market that is
admittedly changing with new technology every day.9" To allow a
governmental mandate to hamstring the journal's attempts at
staying competitive would not only be unfair, but would also
impede the advancements the industry itself has made in becoming
a benchmark of scientific achievement. 91
c. Impact on the Integrity of the Scientific Record
The following arguments require an indulgence of the
publishing doomsday scenario outlined by those who concern
themselves with the potential economic ramifications of the NIH
policy. Were the funding to slip away and were peer review to fall
by the wayside in journals' attempts to stay afloat, H.R. 801
supporters question the existence of any group who is willing to
continue the process. Advocates on both sides agree that peer
review is necessary to produce useful and beneficial scientific
research articles. 92  If the journals can no longer financially
support it, H.R. 801 supporters see two possible alternatives. First,
87. Hearing, supra note 7 at 54 (testimony of Ralph Oman) ("With
plummeting sales, how could the STM publishers stay in business?").
88. Id.
89. Id. at 57.
90. Id.
91. Id. at 57 ("By restoring the status quo ante, the Chairman's bill will give
the evolving free market a chance to come to grips with the new online
technologies without undercutting the incentives that publishers have relied on
for two hundred years.").
92. Id. at 82 (oral testimony of Dr. Elias Zerhouni) ("You cannot just have
self-reported scientific report of activities under grants to replace the full effort
that an author has to make to understand all of the other literature, to write their
publication, submit their data.... [W]hat is key here is to have a database of the
absolute final author's manuscript that is peer reviewed by his peers.").
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the NIH can absorb the time and financial burden involved in peer
reviewing articles.93 Second, the publishing industry could switch
to a model requiring the author to foot the bill of peer review
costs.
94
Both models are met with dim expectations. Dr. Zerhouni stated
that the NIH has no interest in participating in the peer review
process.95 Even if the NIH was willing, Mr. Oman notes that this
is not an arena where a government agency would be welcome. 96
In attempts to keep the publication process in line with the First
Amendment, it is much preferred that selection and editing of
scientific research be left to the private sector.9"
A model requiring authors to pay the costs of publication is
equally as undesirable in the eyes of H.R. 801 supporters.98 In this
"pay to publish" system, publishers could likely lose their
objective eye and impartial goal of information dissemination.9
Supporters reiterate that the role of publishing companies in
scientific research is to create and enforce somewhat of a hierarchy
in their fields.' 0 Publication in particular journals should denote
93. Hearing, supra note 7 at 55 (testimony of Ralph Oman). Mr. Oman
proposes and quickly dismisses the prospect of the NIH taking over peer review,
saying that "as a general rule Congress prefers to keep the hairy snout of the
federal government out of the peer-review and manuscript selection process.
We live in an open society, and, with a weather eye on the First Amendment, we
try to keep the government at arms length from these delicate publication
decisions, so as not to skew the process." Id.
94. Id. at 124 (written responses of Ralph Oman).
95. Id. at 86.
96. Id. at 55 (oral testimony of Ralph Oman).
97. Id.
98. See id. at app at 124 (written responses of Ralph Oman) ("If we were to
give the authors the choice between the original system - with private
publishers subsidizing review and publication costs from their paid
subscriptions - and a new system that required the authors to pay a high fee to
subsidize the publication, I suspect that the authors would favor the current
system.").
99. Hearing, supra note 7 at 124 ("As an observer of human nature, I would
also be suspicious of any journal that published the articles of an author who
paid them to publish it.").
100. Id. at 56-57 (written testimony of Ralph Oman) ("The NIH itself
recognizes that 'publication in peer-reviewed journals is a major factor in
determining the professional standing of scientists; institutions use publication
in peer-reviewed journals in making hiring, promotion, and tenure decisions."').
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the prestige and accountability that those journals have
accumulated and cultivated through the life of the publications.' 0
When the system breaks down to "pay to publish," the negative
impacts would be felt by researchers, publishers, and the American
public alike as the quality of research would have to be weighed
against the price the author was willing and able to pay.'0
d. Sufficiency of Existing Public Access Avenues
It must not be assumed that a vote for H.R. 801 is a vote against
public access. Supporters commend the several avenues for public
access to medical research that already exist.' 3 Their argument is
simply that these existing options are more than sufficient, and the
NIH public access policy is unnecessarily damaging to the
copyrights and economic futures of the parties involved."
Among these popular public access options are PatientInform.org,
The D.C. Principles, and the journals' own websites.
Patientlnform.org is a project of the American Cancer Society,
American Heart Association, and American Diabetes
Association. ' Nearly twenty-five publishers submit their
biomedical journal articles to the open access program, allowing
free access to the full text of the articles." 6 The website presents
"patient-friendly" summaries of articles and new discoveries along
with links to the free, full text of the article. "' PatientInform
101. Id.
102. See id. at 124 (oral testimony of Ralph Oman) Mr. Oman's concern is
that wealthy authors, institutions, and journals would be given the implicit
opportunity to purchase credibility. Prestigious journals would no longer reflect
the most worthy research, but instead would fill their pages with articles from
authors and educational institutions with the most funding.
103. See id. at 71 (oral testimony of Dr. Martin Frank) Dr. Frank mentions
the D.C. Principles, HINARI, Agora, and PatientInform as open access
initiatives that have already achieved high levels of acceptance and success.
104. See id. at 117 (letter submitted to the hearing record by Dr. Martin
Frank on behalf of APS in response to Congressman Berman's November 12,
2008 Request) (expanding on descriptions and praise of existing open access
platforms and their sufficiency in place of the NIH policy).
105. PatientInform - Background Information, http://www.patientinform.co
m/what-is-patientinform (last visited Aug. 1, 2009).
106. Id.
107. PatientInform - How to Use PatientInform,
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focused its pilot public access program on articles relating to
cancer, diabetes, and heart disease.' 8 At this time, it is extending
its services into a wider range of medical conditions. 109
Signatories to the D.C. Principles for Free Access to Science
include nearly 400 journals, representing seventy-three publishers
who are committed to providing public access to their articles."'
These publishers provide free access to the full text of their entire
journals online, but at a time after publication that is chosen by the
publisher.'"' This qualification - the choice by the publisher of
when they wish to make their articles available to the public - is a
clause that possibly, in the eyes of H.R. 801 supporters, could have
saved the NIH policy."2 A constant criticism of the NIH policy is
that "one size fits all" does not work for a diverse publishing
industry. "3
The strongest evidence that demonstrates that H.R. 801
supporters do indeed support access is to look at their own
websites. Though often used as a sword against them, many
publications make the choice to publish the full text of their
articles on their websites for free." 4 The operative word for them
here is "choice.""' 5 Dr. Frank explained to the Subcommittee, via
his written testimony, the American Physiological Society's choice
http://www.patientinform.com/how-to-use-patientinform (last visited Aug. 1,
2009).
108. PatientInform - Scope of the Program, http://www.patientinform.com
/scope (last visited Aug. 1, 2009).
109. Id.
110. Washington D.C. Principles for Free Access to Science - Signatories,
http://www.dcprinciples.org/signatories.htm (last visited Aug. 1, 2009).
111. Hearing, supra note 7 at 71 (oral testimony of Dr. Martin Frank).
112. Id. at 123 (letter submitted to the hearing record by Dr. Martin Frank on
behalf of APS in response to Congressman Berman's November 12, 2008
Request) ("Since every niche of science is different, no one embargo period will
suit all journals.").
113. Id.
114. Id. at 59 (oral testimony of Heather Joseph).
115. Id. at 74. (oral testimony of Dr. Martin Frank). Dr. Frank describes the
existing APS policy regarding open access, noting that they make all articles
freely available at HighWire Press 12 months after publication, but that this
policy is open to modification should it prove detrimental to the APS business
model.
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to post full journal texts online twelve months after publication.'16
He was careful to note that the benefit of a self-imposed policy is
the ability to roll it back should economic conditions change or
should it be deemed to no longer serve the audience intended."7
Dr. Frank then tied copyright protection into his argument for self-
control over access: "We were able to make the decision [to
provide access] because the Society controlled copyright on the
articles and we had subscription revenue to support the necessary
infrastructure.""' 8  Dr. Frank's precise testimony provided the
strongest argument that H.R. 801 supporters are heard to make:
just let us do it ourselves." 9
e. NIH Unwillingness to Collaborate
In addition to their arguments for the immediate and far-
reaching implications of H.R. 801, the bill's supporters have made
comments alleging that the NIH is unwilling to cooperate with the
groups who oppose its public access policy. 2 ' A specific example
involves the NIH's refusal to make use of existing identification
markers for genes and chemical compounds.' 2 These ID codes are
used throughout the biomedical field as reference points; they
allow readers and researchers to recognize when a gene or
compound is being referenced in multiple articles.'22 Instead of
utilizing these existing markers, the NIH has imposed its own
116. Id.
117. Hearing, supra note 7 at 74. (oral testimony of Dr. Martin Frank).
118. Id.
119. Id.
120. Id. at 119 (letter submitted to the hearing record by Dr. Martin Frank on
behalf of APS in response to Congressman Berman's November 12, 2008
Request).
121. Id. at 118-19.
122. One example of this type of identification system is the number registry
system used by the Chemical Abstracts Service, a chemical database maintained
by the American Chemical Society. When someone lists a chemical substance
in the database, it is assigned a unique registry number. Because chemical
nomenclature can vary around the world and even between scientific fields, the
registry number allows a scientist to precisely note which chemical compound
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identification system within PMC. 23 While this is important for
maintaining consistency within PMC, it renders articles within
PMC incompatible with the identification systems used
elsewhere.'24 This practice seems to go against the NIH's stated
goal of providing an integrated network of articles, genes, and
compounds. 
25
Publishing groups, in particular, find themselves at odds with
the NIH, because it has not released statistical information on
which articles are being accessed and with what frequency. The
economic impact of the policy has been a contentious topic
between the groups primarily because neither side has been able to
provide solid economic data to support their opposing positions.
The journals are unable to provide independent evaluations of how
PMC has affected readership because the NIH will not release the
information they require. 2 6
The final circumstance leaving a bitter taste in the mouths of
H.R. 801 supporters is that the public access policy was never
subjected to the rigorous Congressional hearings and scrutiny that
H.R. 801 will have to endure. Though Congress had a role in
making recommendations regarding the policy, 127 it was made
mandatory and subsequently permanent by riders attached to
massive annual appropriations bills and not by a separately
evaluated mandate. 
28
123. Hearing, supra note 7 at 119 (letter submitted to the hearing record by
Dr. Martin Frank on behalf of APS in response to Congressman Berman's
November 12, 2008 Request).
124. Id.
125. See id. at 23-25 (oral testimony of Dr. Elias Zerhouni).
126. The NIH maintains that they are unable to compile and release this
information due to the National Library of Medicine's privacy policy. See
Hearing, supra note 7 at app. at 100 (Dr. Zerhouni's response to questions from
the Subcommittee submitted to the hearing record) ("The National Library of
Medicine has a privacy policy for PubMed Central which precludes the
identification of individual users or institutions in its usage data.").
127. See, e.g., supra notes 25-26.
128. Hearing, supra note 7 at 53. (written testimony of Ralph Oman) Mr.
Oman presents his concern that the language of the NIH policy was included in
an appropriations bill and was never vetted by the Judiciary Committee, which
generally has jurisdiction over and the most expertise in intellectual property
issues.
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2.... All Opposed?
As qualified and notable as the bill's supporters are, they can
count an equally influential group as their adversaries. University
deans and provosts, library associations, the Scholarly Publishing
and Academic Resources Coalition, groups of law professors and
thirty-one Nobel Prize winners have collectively expressed their
concerns over the passing of H.R. 801. 129 Paramount to their drive
against the bill is their perception that it aims to restrict and
ultimately abolish public access to biomedical research.13
Additionally, they express concerns about the bill preemptively
trying to protect the publishing industry's profits, a number that
they say is in no danger of decline. 131
a. Restricted Access to Medical Information
The most common argument against H.R. 801 is that the bill
will prohibit the public from having access to the medical research
it has already underwritten through its taxes."' Because of rising
journal subscription prices, they envision a future where the public
has no avenue to access this research at a reasonable price, and
many doctors and universities may have to cancel subscriptions
and therefore lose their access as well. When Heather Joseph told
the story of her son's diabetes diagnosis,133 she mentioned that
129. See id. at app. at 188.
130. Id. ("The clientele for this knowledge are not just an esoteric group of
university scientists and researchers who are pushing forward the frontiers of
knowledge. Increasingly, high school students preparing for their science fairs
need access to this material so that they too can feel the thrill of research.
Teachers preparing courses also need access to the most up-to-date science to
augment the inevitably out-of-date textbooks. Most importantly, the lay public
wants to know about research findings that may be pertinent to their own health
diagnoses and treatment modalities.").
131. Id. at 66 (testimony of Heather Joseph).
132. Id. at 58 ("U.S. taxpayers underwrite tens of billions of dollars [of]
research each year and the sharing of this research is an essential component of
our collective investment in science. Yet, despite the fact that we have paid for
this research, members of the public frequently cannot access these findings,
because they simply can't afford to subscribe to all of the journals in which they
are published.").
133. See supra Section II.A.
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open access would not only allow her to read information on the
condition, but also allow every diabetes researcher in the world to
access the pool of diabetes information and research supported by
the NIH in order to develop a cure for children like her son.'34
Without free public access, opponents say, science cannot progress
to its fullest potential. 35
In his testimony before the Subcommittee, Dr. Zerhouni
demonstrated the interconnectivity capabilities of the PMC system,
a resource that would be far less robust and useful if H.R. 801
were to pass.'36 Within the PMC database, articles are enhanced
by adding internal identifiers to relevant genes, chemical
compounds, and even other relevant articles on PMC.'37 Dr.
Zerhouni considers this article enhancement the great
improvement of the NIH policy over existing public access
avenues.'38 If H.R. 801 were to be enacted, this treatment could
only be given to the articles that are voluntarily deposited into
PMC; during the test run for the policy, this number stayed around
a disappointing seven percent'39 of eligible articles.'40 This meager
134. Hearing, supra note 7 at 95 ("I want every scientist working on diabetes
research to have information ... access to the information or the research that
we are funding, and make these new and novel connections that are needed to
make the leaps to move from basic research at the NIH to treatment for this kind
of a disease.").
135. Id. at 59 ("This bill would significantly inhibit our ability to advance
scientific discovery.").
136. Id. at 17-18 (oral testimony of Dr. Elias Zerhouni). Dr. Zerhouni
provided a short demonstration of the linking capabilities within PubMed
Central. Using the example of a search for information on ovarian cancer, he
demonstrated that one could link from one paper on ovarian cancer to a list of
related articles, to the relevant gene in a gene database, and to the structure of
relevant substances and proteins.
137. Id.
138. Id. at 23-25.
139. NIH, supra note 30.
140. The reasons for this poor showing at the initially voluntary level for
PMC deposition has not been fully expolored or discussed by the parties. In his
testimony at the hearing on H.R. 6845, Dr. Frank suggested that, at that time,
PMC was burdened with a confusing and difficult upload process, as well as
poor communication to the research community about the benefits of PMC.
Hearing, supra note 7 at 84 ("1 think the voluntary plan that NIH instituted was
belabored with a somewhat cumbersome upload process and mixed signals to
the investigator community."). As a result of the current, well-publicized
25
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portion of the available research would doom the research-
enhancing possibilities of this particular aspect of PMC.
b. Overprotective of Publishing Profits
The second major criticism of H.R. 801 relates to the publishing
industry directly. Some say that this bill was introduced solely as
a result of publisher lobbying, and have gone so far as to accuse
Rep. Conyers and the other bill sponsors of accepting
disproportionate campaign contributions from the publishing
lobby. "' To combat the suggestion that open access will cost
publishers subscription revenue, bill opponents rely on polls taken
of librarians that seem to suggest that the provisions of the NIH
policy do not provide a large enough volume of information at an
early enough time to induce libraries to cancel their journal
subscriptions. '4 2 Heather Joseph presented two points on this topic
in her Subcommittee hearing testimony. She first noted that in the
discussion on the issue, it is likely that cooperation with PMC deposition would
increase because the research community is much more aware of the linking
benefits within PMC. Also, because the period of mandatory deposition has
increased the number of articles within PMC, it can be presumed that the linking
benefit can be much more fully realized and demonstrated, hopefully
encouraging researchers to take part in deposition and reap the benefits for
themselves.
141. Lawrence Lessig & Michael Eisen, Is John Conyers Shilling for Special
Interests?, HUFFINGTON POST, Mar. 2, 2009, http://www.huffingtonpost.com/la
wrence-lessig-and-michael-eisen/is-john-conyers-shilling-b_1 71189.html.
While open access advocates are generally loathe to accept the argument that
the NIH's policy could have a detrimental impact on publisher profits, this
argument seems to concede that it's enough of a possibility to encourage
publishers to lobby on the bill's behalf.
142. Hearing, supra note 7 at 66 (oral testimony of Heather Joseph) (citing
MARK WARE, ALPSP SURVEY OF LIBRARIANS ON FACTORS IN JOURNAL
CANCELLATION, (2006)). Ms. Joseph presented the results of a 2006 report by
the Association of Learned and Professional Society Publishers showing the
following opinions from a majority of surveyed librarians: (1) the publishing
embargo period must be very short, less than three months, for the availability
of an archive like PMC to induce them to cancel journal subscriptions, (2) the
archive would have to contain the final journal version of an article, not the pre-
print version, and (3) the archive would have to hold at least 90% of a journal's
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field of biomedicine, twelve months after publication is a very
long time.'43  In this field, she said, information that old is
considered out of date; ' therefore, librarians and subscribers will
still be willing to pay journal subscription fees in order to have
access to the information immediately upon publication.'45 Ms.
Joseph's second point characterized the publishing industry's
response to the NIH policy as something near hypocrisy, as she
pointed out that many of these journals do exactly what PMC
intends to do: they publish the full text of their articles on their
website, free for anyone to access.'46  She argued that if the
journals are already doing it themselves, the posting of articles in
PMC could not have any measurable effect on their profits. "'
143. See id. at 58 ("In the fast-moving world of biomedical research,
information after 1 year is old.").
144. The inherent contradiction in this argument repeatedly put forth by Ms.
Joseph has, for some reason, not been addressed by the publishing industry.
Ms. Joseph stresses the need for providing this information to the public so they
may take advantage of the most cutting-edge research in their respective fields
of interest. Hearing, supra note 7 at 58. However, only moments later, she
dismisses publisher concerns about losing revenue by saying that, after 12
months, the published information is out of date and superseded by the newest
research. Id. It is unclear why she feels it is so imperative to provide the public
with this "out of date" information. This contradictory argument is not the only
poorly crafted response by Ms. Joseph. When addressing the rising cost of
journal subscription, she paints a picture of universities and libraries struggling
to support the cost of the journal required and requested by their constituents.
However, she provides a study saying that free access to this content will have
no effect on subscriptions. This seems to imply that the financial burden on
these libraries is not as dire as suggested. Id. at 66.
145. Hearing, supra note 7 at 137 (SPARC response submitted to the hearing
record) (noting that journal website usage peaked during the period where
articles were still embargoed, indicating that users were still willing to pay
journal fees to read information immediately after publication).
146. Id. at 130 ("[A]ctive practices within the biomedical journal publishing
community indicate that the requirements of the NIH Public Access Policy are
not a threat to their well-being.").
147. Id. ("[I]f the free availability of an author's final manuscript after one
year truly would cause libraries to cancel subscriptions to biomedical journals
and result in financial losses, then journal publishers surely would not
voluntarily implement such a practice. Yet, there are hundreds of biomedical
journals who do just that .... ").
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IV. ANALYSIS
The continued struggle between public access advocates and the
publishing industry will be difficult to resolve, due to both the
strength of arguments and the validity of the principles those
arguments stand for. From a purely argumentative standpoint, it is
difficult to form a position against the basic principle that the
public should have access to research that its tax dollars paid for.
Similarly, it would be difficult to find someone to agree with the
idea that the government should be able to strip an author of rights
to his work without adequate compensation. It is likely that
anyone would find their gut reaction to be in alignment with the
arguments for both parties.
Instead of championing their opposing solutions and waiting to
see which side ultimately "wins," both sides should consider
which points they are willing to concede in return for flexibility on
issues they deem more important. Upon coming to these
fundamental agreements, the group can than turn to two existing
pieces of legislation, America COMPETES'48 and the Bayh-Dole
Act'49 and evaluate each in turn for guidance on the relevant
issues. With this foundation of stipulated conditions and
legislative guidance, a framework can be built that will bring us
much closer to a system that can work for everyone. What follows
is a walk through this process, resulting in proposed legislative
language.
A. Instructive Existing Legislation
Both of the following pieces of legislation, America
COMPETES 5 ' and the Bayh-Dole Act,' have been proposed as
148. See generally America Creating Opportunities to Meaningfully Promote
Excellence in Technology, Education and Science Act, 2007, ("America
COMPETES") Pub. L. No. 110-69, 121 Stat. 572 (2007).
149. See generally Bayh-Dole Act, 35 U.S.C. §§ 200-212 (2006).
150. Hearing, supra note 7 at 72 ("The NIH could have provided access to
its funded research without diminishing copyright protection. It could have
followed Congress' direction under the America Competes Act, which
authorized NSF to provide access to research reports and summaries, as well as
citations to copyrighted articles, rather than the articles themselves.").
151. Id. at 97 ("I think the lessons that we learned ... from Bayh-Dole are
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either models or substitutes for a new public access policy. Each
can provide guidance to the framers of this new policy. America
COMPETES included authorization by Congress to the National
Science Foundation ("NSF") to provide summaries of their funded
research to the public for free.'52 The implementation of this
policy is imminent, and is instructive here with regard to which
"strand" of copyright, if any, should be subject to the new public
access policy. Additionally, the Bayh-Dole Act, addressed thirty
years ago, faced nearly the exact same question we are faced with
today through the issue of government-funded patents and their
corresponding rights.'53 Like America COMPETES, Bayh-Dole's
implementation has been successful, and its built-in safeguards can
provide guidance to those who fear that anything less than a
Congressional mandate will result in halfhearted participation,
ultimately rendering PMC and its goals obsolete.
1. America COMPETES: A Model
Passed in 2007, America COMPETES was a massive bill aimed
at improving the United States' position in the world with regard
to education, technology, science, and innovation.'54  Some
provisions in the Act worked toward the goal of increased public
awareness of scientific research by authorizing the NSF to collect
and disseminate reports and summaries of the research it funded to
the public at no cost.'55 In addition to the detailed summaries of
the research, citations and links to full copyrighted articles are
provided so that the reader may purchase the full, formal article if
desired.'56 The summaries are submitted by the researchers and
very relevant here today.").
152. America COMPETES, § 7010 ("The Director shall ensure that all final
project reports and citations of published research documents resulting from
research funded, in whole or in part, by the Foundation, are made available to
the public in a timely manner and in electronic form through the Foundation's
Website.").
153. See Scott D. Locke, Patent Litigation over Federally Funded Inventions
and the Consequences of Failing to Comply with Bayh-Dole, 8 VA. J.L. & TECH
3 (2003).
154. America COMPETES § 1006.
155. America COMPETES § 7010.
156. NATIONAL SCIENCE FOUNDATION, QUARTERLY NEWSLETTER, (May
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prepared specifically for the public in order to keep the public
apprised of the research that results from the award of an NSF
grant. 157
Although this system has yet to be put into effect, it represents a
possible compromise that could be applied to the NIH's desire for
public access to research. H.R. 801 opponents have expressed
their concern that researcher-prepared summaries would rob the
public of the benefit of the publisher-provided added value of peer
review.158 Because of the NIH's desire to provide the research at
this final point in its development, a new policy could simply
require that the summary be prepared after the peer review process
has been completed. This approach could alleviate the concerns
expressed by Dr. Zerhouni about providing inaccurate or
incomplete research.'59 Additionally, providing summaries of
research could result in an even greater dissemination of this
information. Though there are many patients interested in the
minute details of their possible treatment options, it is just as likely
that there are patients out there overwhelmed by the technicality of
the research papers provided in PMC. Author-composed
summaries directed at a layperson may provide the relevant
information to a wider public base, as these summaries would
probably be much easier to digest and understand. Although these
summaries would not contain the in-depth and highly technical
language that may be desired by a researcher or scientific author,
they would provide sufficient information to let a researcher know
that the article itself likely does contain the relevant information.
This mechanism could result in more efficient spending by
researchers on articles or journal subscriptions being used for their
2009) http://www.nsf.gov/pubs/policydocs/newsletter/mayO9/index.html#two
("NSF anticipates that beginning in fall 2009, PIs will be required to prepare a
brief summary - specifically for the public - on the nature and outcomes of the
award which will be posted on the Foundation's website.").
157. Id.
158. Hearing, supra note 7 at 82 (oral testimony of Dr. Elias Zerhouni)
("You cannot just have self-reported scientific report of activities under grants
to replace the full effort that an author has to make to understand all of the other
literature, to write their publication, to submit their data. .... What is key here is
to have a database of the absolute final author's manuscript that is peer reviewed
by his peers.").
159. Id. at 92 (oral testimony of Dr. Elias Zerhouni).
156 [Vol. XX: I
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own scientific purposes.
2. Bayh-Dole: Power to the People
Enacted nearly thirty years ago, the Bayh-Dole Act and its
supporters fought almost exactly the same fight that H.R. 801
supporters are fighting today. 6 ' At issue were the patent rights to
inventions and the related intellectual property created with
government funding. After much lobbying on the part of
inventors, Congress enacted the Bayh-Dole Act, which allows a
university, non-profit, or small business to retain the rights to their
inventions even though those inventions were supported by federal
funding."'6 The first section of the Act lays out the policy behind
this decision, focusing mostly on the desire to allow the private
market to commercialize these inventions and promote free
competition to the benefit of the public.162 Congress felt that the
federal government was ill-equipped to do such a job, because at
that time, only five percent of government-owned patents were
being marketed commercially.163 The Act also includes a few
safeguards to ensure that the true goal of the Act, promoting the
160. See Locke, supra note 153 at 3.
161. Id. at § 202(a) ("Each nonprofit organization or small business firm
may, within a reasonable time after disclosure as required by paragraph (c)(1) of
this section, elect to retain title to any subject invention .... ").
162. Id. at § 200 ("It is the policy and objective of the Congress to use the
patent system to promote the utilization of inventions arising from federally
supported research or development; to encourage maximum participation of
small business firms in federally supported research and development efforts; to
promote collaboration between commercial concerns and nonprofit
organizations, including universities; to ensure that inventions made by
nonprofit organizations and small business firms are used in a manner to
promote free competition and enterprise without unduly encumbering future
research and discovery; to promote the commercialization and public
availability of inventions made in the United States by United States industry
and labor; to ensure that the Government obtains sufficient rights in federally
supported inventions to meet the needs of the Government and protect the
public against nonuse or unreasonable use of inventions; and to minimize the
costs of administering policies in this area.").
163. U.S. Gen. Accounting Office, GAO/RCED-98-126, Technology
Transfer: Administration of the Bayh-Dole Act by Research Universities 3
(1998) available at http://www.gao.gov/archive/1998/rc98126.pdf.
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commercialization of these inventions, is accomplished."6 One of
these safeguards reserves for the federal funding agency a "march-
in" right.'65 If the agency that funded an invention determines that
the patent holder has not taken reasonable steps to commercialize
the invention, that agency can "march in" and grant additional
licenses to other applicants in order to insure that the invention is
being commercialized to the fullest possible extent.'66
The Bayh-Dole Act provides significant guidance as a new
public access policy is crafted. Here, Congress made a policy
judgment with regard to inventions by presuming that the private
sector is best suited to control the commercialization and
dissemination of patents and inventions. This general attitude,
allowing the private sector to put their commercialization skills to
use, could be helpful in swaying the NIH to concede that the
existing framework for STM publication should remain intact.
The publication and dissemination of the research the NIH hopes
to provide to the public are contingent on approval and review by
journals. '67 Dr. Zerhouni conceded that the government wanted no
164. Bayh-Dole Act, § 203.
165. Id., in relevant part:
"(a) With respect to any subject invention in which a small
business firm or nonprofit organization has acquired title
under this chapter, the Federal agency under whose funding
agreement the subject invention was made shall have the
right, in accordance with such procedures as are provided in
regulations promulgated hereunder to require the contractor,
an assignee or exclusive licensee of a subject invention to
grant a nonexclusive, partially exclusive, or exclusive license
in any field of use to a responsible applicant or applicants,
upon terms that are reasonable under the circumstances, and if
the contractor, assignee, or exclusive licensee refuses such
request, to grant such a license itself, if the Federal agency
determines that such
(1) action is necessary because the contractor or assignee has
not taken, or is not expected to take within a reasonable time,
effective steps to achieve practical application of the subject
invention in such field of use ......
Id.
166. Id.
167. Hearing, supra note 7 at 92 (oral testimony of Dr. Elias Zerhouni)
("[W]e do not want publishers not do [sic] peer review. We actually support the
role of publishers. . . .For us to take non-peer reviewed articles would be
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part in providing that service of transforming raw research papers
into publishable, desirable articles.168 The STM publishers are
ready, willing, and able to handle this process, and there is no
demonstrable evidence to show that any other group could provide
the same level of service at a greater public benefit.
An analogue to the § 203(a)(1) safeguard in Bayh-Dole can
provide the safety net desired by the wary, such as Ms. Joseph.
She claims that publishers will continue to raise their prices and
cut off access to the general public.'69 In the new public access
policy, the NIH could reserve the right to initiate its own method
of providing public access if a certain journal has not complied
satisfactorily. Setting a "satisfactory" level would require
negotiation, but would serve as notice to all journals carrying NIH-
funded research that they must provide some level of free public
access to that research. This serves the interest mentioned above
regarding flexibility by allowing journals to craft their own public
access policies and modify them as needed within the restrictions
of the NIH guidelines.
An ideal extension of this policy would expand this requirement
to all STM journals, not only those that feature NIH funded
research. Broad application of the policy would eliminate the
concerns that NIH policy disproportionately burdens journals with
a majority of NIH research and would serve the greater goal of
providing all medical research to the public. The great benefit of
this option is that it shifts the condition of public access from the
NIH funding contracts to the publication negotiations. NIH
researchers would no longer be restricted to journals that accepted
the current public access conditions. Instead, authors would have
their choice of journals with a wide array of public access policies,
every one of them in some way compliant with the new umbrella
against every cautious, prudent management of science.").
168. Id. at 86 ("We don't want to do peer review ... ").
169. Hearing, supra note 7 at 63 (testimony of Heather Joseph) ("Even the
most well-funded, private university libraries cannot afford to subscribe to all of
the journals they would like to provide their students. This situation is
exacerbated by the continued rapid escalation in price of journal subscriptions,
which puts libraries in the position of having to cancel subscriptions. Libraries
now routinely find themselves in the position of paying more and more money
only to be able to provide their patrons - students, faculty, researchers - with
access to less and less.").
159
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policy. The author may select a journal with a public access policy
in alignment with the author's own desire for the publication and
dissemination of their article.
B. A Three-Part Foundation
Before any mutually acceptable conclusion can be reached with
regard to public access to taxpayer-funded medical research, there
are three issues that the opposing groups must come together and
agree upon. First, the interested parties must come to an
agreement on where the funding for the publication and peer
editing processes comes from. Second, they should decide upon a
framework wherein the choice to transfer any aspect of copyright
is truly voluntary in order to respect existing copyright law.
Finally, they must devise either a system that is flexible upon a
showing of hardship in complying with the public access policy or
a system that is universally beneficial, regardless of a journal's
status in terms of size or profitability. Though these are not the
only contested issues between the parties, the resolution of these
three contentious questions would lay the foundation for a piece of
legislation that would represent an acceptable resolution to the
quandary of providing public access to medical research while still
reserving the appropriate copyrights for authors.
1. Who Truly Pays for Publishing Costs?
The first major issue that the publishing industry and public
access advocates cannot seem to agree on is the actual source of
funding for the publishing and peer-review process. 7 ' The
resolution of this issue is paramount, because as long as publishers
feel that they are being stripped of the rights to their monetary
investment in peer review, the possibility that they will cease to
provide that service increases. 7' The investment that these
publishers are making goes beyond the process of peer-reviewing
and editing articles in preparation for publication. The selection of
170. See supra Section III(B)(l)(a).
171. Hearing, supra note 7 at 76 (testimony of Dr. Martin Frank) ("These are
costly endeavors, and if publishers cannot recover their costs, the quality of our
journals will suffer to the detriment of our members' science.").
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high quality articles helps to build the brand of the journal. So too,
does the solicitation of ad revenue for both print and electronic
versions of the journal. All of these aspects of running a journal
cost money, and these are supported by a "reader-pays"
subscription model. The implementation of the NIH policy and
the deposition of journal articles into PMC affects all aspects of a
journal's investment. When a member of the public reads a
journal article on PMC instead of the journal's own website, the
reader does not see the advertisements solicited by the journal or
realize that the article is associated with the branding and
distinctive design of the journal or its website. The article is,
however, of the quality that the journal required to be published in
the first place. Each of these represents a missed return on
investment for the journal. What will motivate journals to solicit
high-quality articles, prestigious peer reviewers, relevant
advertisements, and pleasing design if none of these investments
are supported by subscription profits?
Conversely, the NIH argues that it provides a cushion of $3,000-
4,000 in its grants to cover publication costs.172 Though this would
account for the added value of peer-review in the articles
submitted in PMC, it does not address the other avenues where
publishers feel they are being robbed of potential return on their
investments.
It is likely that this issue can only be resolved by an economic
study of how grant money is spent by NIH-funded researchers. If
it can be shown that the fees collected by journals from authors for
publication costs do in fact come from those authors' grant
budgets and that this money represents an adequate return on the
various investments made by the journals, then the STM
publishers may have lost this battle.
2. What is the Definition of Voluntary?
The language in the 2009 Appropriations Bill that rendered the
NIH public access policy permanent includes a clause that reads:
"[T]he NIH shall implement the public access policy in a manner
172. Id. at 82 (oral testimony of Dr. Elias Zerhouni) ("[W]e allow our
grantees to pay $3,000 to $4,000 to the publishers for page charges,
reproduction charges.").
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consistent with copyright law."' 73  It was suggested at the H.R.
6845 hearing that this clause suggests that the NIH public access
policy is not inherently consistent with current copyright law and
that the current implementation of the policy goes against this
provision.'74 The crux of this question rests at the definition of
"voluntary." The suggestion that these NIH grants are contracts of
adhesion has some teeth, and must be addressed.
Generally, a court will consider a contract one of adhesion if it is
a standardized contract prepared entirely by one party for the
acceptance of another on a "take it or leave it" basis, due to the
unequal bargaining power of the parties and under conditions that
the second party cannot receive the desired product or service
unless they acquiesce.175 This description from the Seventh Circuit
is analogous to the NIH grant situation. Authors have no
opportunity to negotiate with the NIH with regard to the public
access provision of the grant contract.'76 However, this adhesion
evaluation has another side. A court will also take into
consideration how unconscionable the contract term at issue is.'
To be considered an adhesion contract, the terms must be so
oppressive that no reasonable party would make or accept them.'78
173. See Omnibus Appropriations Act, 2009, Pub. L. No. 111-8, § F(217),
123 Stat. 524, 782; See also supra note 38.
174. Hearing, supra note 7 at 51 (oral testimony of Ralph Oman) ("You,
Congress, were telling [Dr. Zerhouni] to figure out a way to accomplish
Congress' public access objectives in a way that respects copyright.").
175. De Valk Lincoln Mercury, Inc. v. Ford Motor Co., 811 F.2d 326, 333
(7th Cir. 1987) ("The essence of an adhesion contract is that it is offered on a
take it or leave it basis to a consumer who has no realistic bargaining strength
and who cannot obtain the desired services or goods without consenting to the
contract terms.").
176. See Hearing, supra note 7 at app. at 109 (letter submitted to the hearing
record by Allan Alder, Vice President for Legal & Government Affairs,
Association of American Publishers) ("Given the sway and influence of the NIH
that undoubtedly comes with its provision of such funding to virtually every
institution in the United State that is involved in medical research, it is simply
untenable to assert, as a practical matter, that an investigator in this field 'elects'
to receive or forego NIH funding.").
177. De Valk., 811 F.2dat 333.
178. Zubi v. Acceptance Indem. Ins. Co., 323 Il1. App. 3d 28, 37 (1I1. App.
2001) ("An unconscionable bargain is one which no reasonable person would
make and which no honest person would accept. The term "unconscionable"
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H.R. 801 supporters feel that involuntary transfer of any "strand"
of copyright qualifies as an oppressive contract term.'79 Though
compliance with a public access policy may not rise to this level of
oppressiveness in the eyes of a court, the pressure could be
alleviated by either offering different ways of complying with
public access mandates or by toning down the language and
ramifications of the existing requirement.
3. Can We Make One Policy Fit All Publishers?
The question of public access policy flexibility is pivotal to the
fight between the publishing industry and the public access
advocates. Even this phrasing, "publishers v. public access" is
inapt, because publishing companies have come out to express
their support for and openness to the idea of public access. 8
These publishers are access advocates themselves, and many of
them already have in place policies that provide their journal
articles free of charge in less time than is mandated by the NIH
policy.'' What they desire is autonomy and flexibility in such a
policy, especially in a time where they are dealing with not only
economic fluctuation, but also the diversification of their industry
as a whole. Without a flexible and fluid policy, allowing journals
to choose their own time embargos on free publication and
allowing them to modify those embargos if economic or other
conditions require, the journals will always fight against the NIH
in order to preserve their economic model.
If this fight continues without resolution, the inevitable result is
that some journals will close their doors, resulting in fewer
publication options for authors. With fewer journals, less research
overall can be published. Also, it may result that authors are
encompasses the absence of meaningful choice by one of the parties as well as
contract terms which are unreasonably favorable to the other party.").
179. Hearing, supra note 7 at app. at 126 (written response of Ralph Oman)
("The author's assignment of a limited right to NIH ... is not 'a small strand of
the worldwide rights.' . . . In fact, this assignment to NIH effectively exhausts
the economic value of the copyright in 99 percent of the cases.").
180. See, e.g., id. at 14 (oral statements of Congressman Darrell Issa).
181. Id. at 74 (oral testimony of Dr. Martin Frank) Dr. Frank describes
generally the free content provided online by the American Physiological
Society.
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eventually able to turn away NIH funding because a substantial
number of journals have chosen not to associate with authors
subject to those funding agreements. The NIH's goals will suffer
even further then, because fewer submitted articles would result in
the ultimate irrelevancy of the linking capabilities of PMC, the true
bonus value of the NIH's original policy.
C. Proposed Policy for the Future
Upon considering the Bayh-Dole Act and America COMPETES
in the context of the three core compromise issues, it becomes
clear that there are several ways to craft a workable public access
policy that better addresses the concerns of STM publishers and
access advocates alike. As previously stated, several agreements,
negotiations, and research studies must be completed before the
precise details of any solution can be decided upon. Without the
benefit of such studies, however, a framework in which to place
these specific provisions can still be built. In order to fully
effectuate the objective of free public access to medical research,
the following proposed policy could be made enforceable against
all of STM publishing, not only NIH-funded studies. However,
implementation of such a broad scope for the policy would likely
require further opportunity for comment by the publishing
industry, so at this time we discuss only the regulation of NIH-
funded studies. The proposed policy framework follows.
The new policy would provide authors with three avenues for
compliance with public access. The first option is identical to the
existing NIH policy parameters: the author may submit their final,
peer-reviewed manuscript into PMC within twelve months of
publication in an STM journal. The second option draws heavily
on the current NSF policy implemented by America COMPETES.
It would allow authors to retain copyrights to their manuscripts by
requiring that they submit only a self-authored summary of their
peer-reviewed article. This summary, however, must be submitted
immediately upon publication and include the necessary
information to allow PMC to link the summary to other works, as
soon as the article is published and in the same way that a full
article would be linked. The third option for public access
compliance would allow the journals to do what they have wanted
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from the beginning: choose a public access timeline that works
within their economic framework and is flexible within boundaries
provided by the NIH. The NIH would provide certain minimum
guidelines for free display of a full article, and these guidelines
would ideally be the result of a lengthy negotiation and comment
period. Hopefully, these guidelines would provide a wide berth
for journals that support the policy behind public access but simply
desire to keep themselves in business at the same time. Under this
third option, deposition into PMC would be voluntary. As noted
previously, 8 ' the true value of PMC has been much better
publicized and described at this point, hopefully resulting in much
higher levels of participation in the database.
Though the third option outlines a policy that seems to cater
directly to STM publishers' request for free choice in the matter, a
Bayh-Dole Act-like safeguard would provide the necessary
balance to the policy. If an NIH-funded author chooses to publish
in a journal that has no public access policy or which has a policy
that does not fit within the parameters provided, the NIH would
then have an opportunity to petition for a transfer of the copyright
back to the NIH. Similar to Bayh-Dole's "march-in" rights, this
would ensure that the objective of free public access was being
met while continuing to preserve copyrights for authors and
journals.
V. CONCLUSION
The legal and ideological struggle between public access to
taxpayer-funded research and preservation of copyrights and
control for publishers is not likely to be resolved soon unless the
opposing sides can find common ground upon which to build a
universally beneficial public access policy. Supporters on both
sides are both vocal and passionate. Even if H.R. 801 is not
passed, the underlying issue will continue to be the source of
vigorous debate. The conflicts to be resolved are far too numerous
to address fully in an article of this scope, but agreements on the
source of publishing and peer-editing process costs, the
characteristics of a truly voluntary transfer, and the proper level of
182. See supra note 140.
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flexibility in any sort of mandatory policy would provide a stable
foundation for a future compromise. Additionally, a look to
existing legislation will likely be instructive in building that model
policy.
The language proposed above is meant as a framework for the
foundation that the parties so badly need as a starting point. It is
also illustrative of this author's belief that such a mutually
agreeable solution is not only possible, but will closely follow the
parties' eventual agreement to come to the table and begin
working cooperatively towards the goal desired by all.
Stephanie Snyder
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